Troglitazone
Troglitazone is a new thiazolidinedione oral antidiabetic agent approved for use        to improve glycaemic control in patients with type 2 diabetes.
 @SUBJECT$  @PREDICAT$  @OBJECT$  approved for use        to improve glycaemic control in patients with type 2 diabetes.